Total costs of chimeric antigen receptor T-cell immunotherapy

Inmaculada Hernandez; Vinay Prasad; Walid F. Gellad

doi:10.1001/jamaoncol.2018.0977

Total costs of chimeric antigen receptor T-cell immunotherapy

Inmaculada Hernandez, Vinay Prasad, Walid F. Gellad

Knight Cancer Institute

Research output: Contribution to journal › Letter › peer-review

92 Scopus citations

Original language	English (US)
Pages (from-to)	994-996
Number of pages	3
Journal	JAMA Oncology
Volume	4
Issue number	7
DOIs	https://doi.org/10.1001/jamaoncol.2018.0977
State	Published - Jul 2018

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1001/jamaoncol.2018.0977

Cite this

@article{a9cbd83f1c4945229583306fe2786f78,

title = "Total costs of chimeric antigen receptor T-cell immunotherapy",

author = "Inmaculada Hernandez and Vinay Prasad and Gellad, {Walid F.}",

note = "Funding Information: Conflict of Interest Disclosures: Dr Prasad reported receiving royalties for his book Ending Medical Reversal and funding from the Laura and John Arnold Foundation to study low-value practices. No other disclosures were reported.",

year = "2018",

month = jul,

doi = "10.1001/jamaoncol.2018.0977",

language = "English (US)",

volume = "4",

pages = "994--996",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "7",

}

TY - JOUR

T1 - Total costs of chimeric antigen receptor T-cell immunotherapy

AU - Hernandez, Inmaculada

AU - Prasad, Vinay

AU - Gellad, Walid F.

N1 - Funding Information: Conflict of Interest Disclosures: Dr Prasad reported receiving royalties for his book Ending Medical Reversal and funding from the Laura and John Arnold Foundation to study low-value practices. No other disclosures were reported.

PY - 2018/7

Y1 - 2018/7

UR - http://www.scopus.com/inward/record.url?scp=85050553467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050553467&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2018.0977

DO - 10.1001/jamaoncol.2018.0977

M3 - Letter

C2 - 29710129

AN - SCOPUS:85050553467

SN - 2374-2437

VL - 4

SP - 994

EP - 996

JO - JAMA Oncology

JF - JAMA Oncology

IS - 7

ER -

Total costs of chimeric antigen receptor T-cell immunotherapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this